LDLR and Hypercholesterolemia: Then we came up with the question: “Can we get insight into whether a novel variant in LDLR or APOB is the underlying cause for the severe hypercholesterolemia based on the metabolome profile?” Indeed, six out of eight carriers of a novel mutation fit in cluster 3, suggesting potential effects of these variants on LDLR-mediated uptake.